An E-platform for Learners

Industries

Pharma Industries

Lupin Launches Generic Rivaroxaban for Oral Suspension in the U.S. Untitled

Untitled

Lupin Launches Generic Rivaroxaban for Oral Suspension in the U.S.

Pharm'Up

Lupin has announced the launch of its generic Rivaroxaban for Oral Suspension, 1 mg/mL, in the United...

AbbVie Invests $70 Million in U.S. Biologics Manufacturing and R&D Expansion

AbbVie Invests $70 Million in U.S. Biologics Manufacturing and R&D Expansion

Pharm'Up

AbbVie has commenced construction on a $70 million expansion of its AbbVie Bioresearch Center (ABC) in Worcester,...

Historic Breakthrough Dr. Reddy’s, Unitaid, CHAI, and Wits RHI Partner to Deliver Affordable Injectable HIV Prevention (Lenacapavir) to LMICs at $40/Year

Historic Breakthrough Dr. Reddy’s, Unitaid, CHAI, and Wits RHI Partner to Deliver Affordable Injectable HIV Prevention (Lenacapavir) to LMICs at $40/Year

Pharm'Up

In a landmark global health collaboration, the revolutionary injectable HIV prevention tool, lenacapavir, is set to become...

Glenmark Seals Multi-Billion Dollar Deal for Next-Gen HER2-Targeting Cancer Drug

Glenmark Seals Multi-Billion Dollar Deal for Next-Gen HER2-Targeting Cancer Drug

Pharm'Up

Glenmark Pharmaceuticals Ltd., through its wholly-owned subsidiary Glenmark Specialty S.A. (GSSA), has entered a major exclusive licensing...

Alkem Laboratories Launches Pertuza (Pertuzumab Biosimilar) in India to Boost Access to HER2-Positive Breast Cancer Treatment

Alkem Laboratories Launches Pertuza (Pertuzumab Biosimilar) in India to Boost Access to HER2-Positive Breast Cancer Treatment

Pharm'Up

Alkem Laboratories Ltd. has officially announced the launch of Pertuza injection 420mg/14mL, an indigenously-developed and manufactured biosimilar...

GSK Pledges $30 Billion Investment in US R&D and Manufacturing, Focusing on Next-Gen Biopharma and AI Untitled

Untitled

GSK Pledges $30 Billion Investment in US R&D and Manufacturing, Focusing on Next-Gen Biopharma and AI

Pharm'Up

GSK plc has announced a monumental commitment to invest $30 billion in its research and development (R&D)...

Dr. Reddy’s Introduces Novel Acid-Blocker Tegoprazan (PCAB®) in India to Combat Widespread Acid Peptic Diseases

Dr. Reddy’s Introduces Novel Acid-Blocker Tegoprazan (PCAB®) in India to Combat Widespread Acid Peptic Diseases

Pharm'Up

Dr. Reddy’s Laboratories Ltd. has announced a significant advancement in the treatment of acid-related gastrointestinal diseases in...

Stryker Launches New R&D Center in Bangalore, Boosting India’s Med-Tech Innovation

Stryker Launches New R&D Center in Bangalore, Boosting India’s Med-Tech Innovation

Pharm'Up

Stryker, a global leader in medical technologies, has announced the opening of a new 140,000-square-foot R&D facility...

Indoco Remedies’ API Plant Earns a Clean Bill of Health from USFDA

Indoco Remedies’ API Plant Earns a Clean Bill of Health from USFDA

Pharm'Up

Indoco Remedies Ltd., a leading pharmaceutical company, has announced that its Active Pharmaceutical Ingredients (API) manufacturing facility...

Caplin Steriles Secures Landmark USFDA Approval for Milrinone Lactate in Infusion Bags, Boosting Generic Portfolio

Caplin Steriles Secures Landmark USFDA Approval for Milrinone Lactate in Infusion Bags, Boosting Generic Portfolio

Pharm'Up

Caplin Steriles Limited, a prominent subsidiary of Caplin Point Laboratories Limited, has announced a significant achievement with...